Multiple Sclerosis Foundation - News & Features

Get Educated
What is MS?

A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Donate
Get Help
Health & Wellness Program

Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Get Involved
MS Awareness Month

An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Events
Test Flyout

lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
About Us
Programs & Grants

More Details

Zoom Conference - Thri... Topic: Thrive While Trying to Survive: Strengthening Connection, Purpose, and Joy in Difficult Times
... /Events/MSF-Events/2020/Teleconferences/Zoom-Conference-Thrive-While-Trying-to-Survive

Assistive Technology P... The Assistive Technology Program provides information about, and funding for, devices that help... /Get-Help/MSF-Programs-Grants/Assistive-Technology-Program

MS Focus Lending Library

Books, DVDs, and CDs are available for loan, by...

Books, DVDs, and CDs are available for loan, by mail across the United States.

Get more details Get more details

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life!

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

MS mental fatigue linked to slower response to high mental activity

July 30, 2020

The findings suggest significant differences between the two groups in use of brain resources in response to increased mental activity.

MS Focus joins effort to preserve copay help for those with chronic diseases

July 28, 2020

MS Focus joined more than 100 organizations to oppose a provision that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases at risk

Study: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan

July 24, 2020

For most patients with MS, the benefits of remaining on their therapy still outweighs the risk. Individual treatment decisions need to be made between the person with MS and their healthcare team.

Survey: Alternative medicine is widespread among people with MS

June 30, 2020

The survey found patients are nine times more likely to talk with their neurologist about the use of alternative therapies than patients in a similar survey conducted in 2001.

Study finds no link between DMTs and Covid-19 severity

June 26, 2020

Researchers found risk factors for severe forms of COVID-19 were neurological disability, age, and obesity, but no link was found between disease-modifying therapies exposure and COVID-19 severity.

Research on MS, gait to lead to more effective fall prevention

June 23, 2020

Researchers: The study leads to the understanding that step length and foot landing angle are two significant factors for maintaining body dynamic balance in people with MS.

Researchers seek participants for lockdown fall-risk study

June 22, 2020

The purpose of the study is to explore the prevalence and circumstances of falls and fall-related injuries.

Experts analyze options for treating MS-related cognitive impairment

June 18, 2020

To date, none of the available medications or disease-modifying therapies for MS are indicated for the treatment of cognitive deficits.

Study: Favorable outcomes reported for COVID-19 patients with MS on Teriflunomide

June 17, 2020

The authors state future studies are necessary to understand what role, if any, teriflunomide therapy may play in COVID-19 infection.

MS mental fatigue linked to slower response to high mental activity

July 30, 2020

The findings suggest significant differences between the two groups in use of brain resources in response to increased mental activity.

MS Focus joins effort to preserve copay help for those with chronic diseases

July 28, 2020

MS Focus joined more than 100 organizations to oppose a provision that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases at risk

Study: Higher severe COVID-19 risk for patients on Ocrevus, Rituxan

July 24, 2020

For most patients with MS, the benefits of remaining on their therapy still outweighs the risk. Individual treatment decisions need to be made between the person with MS and their healthcare team.

Survey: Alternative medicine is widespread among people with MS

June 30, 2020

The survey found patients are nine times more likely to talk with their neurologist about the use of alternative therapies than patients in a similar survey conducted in 2001.

Study finds no link between DMTs and Covid-19 severity

June 26, 2020

Researchers found risk factors for severe forms of COVID-19 were neurological disability, age, and obesity, but no link was found between disease-modifying therapies exposure and COVID-19 severity.

Research on MS, gait to lead to more effective fall prevention

June 23, 2020

Researchers: The study leads to the understanding that step length and foot landing angle are two significant factors for maintaining body dynamic balance in people with MS.

Researchers seek participants for lockdown fall-risk study

June 22, 2020

The purpose of the study is to explore the prevalence and circumstances of falls and fall-related injuries.

Experts analyze options for treating MS-related cognitive impairment

June 18, 2020

To date, none of the available medications or disease-modifying therapies for MS are indicated for the treatment of cognitive deficits.

Study: Favorable outcomes reported for COVID-19 patients with MS on Teriflunomide

June 17, 2020

The authors state future studies are necessary to understand what role, if any, teriflunomide therapy may play in COVID-19 infection.

Rebif label now includes pregnancy outcomes, lactation information

June 05, 2020

Now, new, limited, data shows the presence of interferon beta-1a products in human milk at low levels.

New oral treatment, Zeposia, available for relapsing forms of MS

June 02, 2020

The Zeposia 360 Support program will facilitate access to Zeposia for appropriate patients with MS.

Study: MS risk higher for people living in urban areas

May 27, 2020

Researchers showed the MS risk was 29 percent higher among those residing in more urbanized areas.

Blood test may help predict whose MS will get worse

May 26, 2020

The blood test looks for a nerve protein that can be detected in the blood when nerve cells die.

Mindfulness training shows promise for people with MS

May 20, 2020

One of the reasons that mindfulness training is so promising is because it is an easily accessible treatment for all patients.

Animal study shows human brain cells repair damage in MS

May 20, 2020

Study provides one of the final pieces of evidence necessary to advance treatment strategy to clinical trials.

Study: Local inflammatory cells are characteristic for advanced MS

May 18, 2020

These new findings support the idea that during the late phase of MS, the disease is happening entirely inside the brain.

FDA approves of Bafiertam for MS

May 04, 2020

Bafiertam is a prescription medicine used to treat relapsing forms of MS.

MS Focus at Sea to set sail in 2021

April 27, 2020

We will be exploring the eastern Caribbean on board Celebrity Cruise Line’s Celebrity Apex.

Show More News